Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spironolactone in Alcohol Use Disorder
NCT05807139Phase 1Recruiting
- Sponsor
- National Institute on Drug Abuse
- Start
- Jul 2023
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of spironolactone in alcohol use disorder (AUD) (4 arms), sponsored by National Institute on Drug Abuse. Primary endpoints: Pharmacokinetics of spironolactone and Pharmacokinetics of alcohol. Started Jul 2023; status: recruiting.
02
Drugs
spironolactone
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT05807139.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05807139.